Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Georg von Sprecher has worked on the following 33 EPO patent applications which have been published in the last five years:

EP11732449

IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS

IPC classification:
A61K 31/4375, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP12726226

SUBSTITUTED INDOLE DERIVATIVES FOR THE TREATMENT OF IMMUNOLOGICAL DISORDERS

IPC classification:
A61K 31/496, A61P 37/00, C07D 401/14, C07F 9/141
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12756885

COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 3/00, A61P 11/00, A61P 17/00, A61P 29/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12756879

COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 3/00, A61P 11/00, A61P 17/00, A61P 29/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13729219

COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR ACTIVITY

IPC classification:
A61K 31/4439, C07D 401/14, C07D 403/04, C07D 403/14, C07D 413/04, C07D 413/14, C07D 471/04, C07D 513/04
Applicant:
Novartis AG
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12761655

NOVEL PYRROLO PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 29/00, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723889

TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
A61K 31/00, A61K 31/137, A61K 31/661, A61P 37/06
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707037

SALTS OF AN IP RECEPTOR AGONIST

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705579

7,8- DIHYDROPYRIDO [3, 4 - B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705578

FUSED PYRROLES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705581

FUSED DIHYDROPYRIDO [2,3 -B]PYRAZINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707437

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PAH AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705582

FUSED PIPERIDINES AS IP RECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) AND RELATED DISORDERS

IPC classification:
A61K 31/4985, A61P 9/00, A61P 11/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12715201

PYRAZOLO PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 9/00, A61P 11/00, A61P 19/00, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13720079

CRYSTALLINE FORM OF A SUCCINATE SALT

IPC classification:
A61K 31/438, A61P 11/00, A61P 35/00, C07D 471/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11715325

COMPOUNDS (CYSTEIN BASED LIPOPEPTIDES) AND COMPOSITIONS AS TLR2 AGONISTS USED FOR TREATING INFECTIONS, INFLAMMATIONS, RESPIRATORY DISEASES ETC.

IPC classification:
A61K 31/17, A61K 31/198, A61K 31/661, A61K 38/10, A61P 11/00, A61P 17/00, A61P 29/00, A61P 31/00, A61P 35/00, C07C 323/60, C07K 5/04
Applicant:
Novartis AG
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11796872

COMPOSITIONS AND METHODS FOR MODULATING FXR

IPC classification:
A61K 31/46, A61P 3/00, C07D 451/06, C07D 471/04, C07D 487/04
Applicant:
Novartis AG
Agent:
Simon John Kiddle, Mewburn Ellis LLP
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
The patent has been granted
EP13779364

BICYCLIC HETEROARYL CYCLOALKYLDIAMINE DERIVATIVES AS INHIBITORS OF SPLEEN TYROSINE KINASES (SYK)

IPC classification:
A61K 31/5025, A61P 11/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Agent:
Emma Marie Bassinder, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13801770

COMPOUNDS FOR USE IN GASTRIC COMPLICATION

IPC classification:
A61K 31/437, A61K 31/519
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13792100

SUBSTITUTED INDOLE DERIVATIVES

IPC classification:
A61K 31/496, A61P 37/00, C07D 401/14, C07F 9/6558
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14707841

IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS

IPC classification:
A61K 31/4375, A61P 3/10, A61P 7/02, A61P 9/10, A61P 11/06, A61P 19/04, A61P 29/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
PATENT GRANTED
EP14708330

TREATMENT OF GRAFT VERSUS HOST DISEASE IN TRANSPLANT PATIENTS

IPC classification:
A61K 31/137, A61K 31/255, A61K 31/519, A61K 31/661, A61K 31/675, A61K 31/7076, A61K 38/13, A61N 5/00, A61P 37/06
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP11757864

PYRAZINE DERIVATIVES AS ENAC BLOCKERS

IPC classification:
A61K 31/497, A61P 11/00, C07D 241/26, C07D 403/12, C07D 487/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11730637

TETRAHYDRO-PYRIDO-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/517, A61P 29/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779606

DOSING REGIMES FOR THE TREATMENT OF OCULAR VASCULAR DISEASE

IPC classification:
A61K 31/4709, A61K 31/505, A61K 31/506, A61K 31/519, A61P 27/02
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11720419

DOSAGE REGIMEN OF DIARYL SULFIDE DERIVATIVES

IPC classification:
A61K 31/145, A61P 37/08
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14821285

NOVEL AMINO PYRIMIDINE DERIVATIVES

IPC classification:
C07D 239/47, C07D 401/10, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/12
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14833234

HETEROARYL BUTANOIC ACID DERIVATIVES AS LTA4H INHIBITORS

IPC classification:
A61K 31/41, A61K 31/415, A61K 31/42, C07D 231/12, C07D 257/04, C07D 271/10, C07D 401/12, C07D 413/12, C07D 417/12
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP10782331

CYCLOHEXANE DERIVATIVES AS INHIBITORS OF ACETYL-COA CARBOXYLASE (ACC)

IPC classification:
C07D 207/06, C07D 207/08, C07D 207/263, C07D 211/16, C07D 211/18, C07D 213/40, C07D 213/71, C07D 241/04, C07D 241/08, C07D 265/30, C07D 277/26, C07D 279/12, C07D 295/088, C07D 401/06, C07D 413/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11701825

ARYL BENZYLAMINE COMPOUNDS

IPC classification:
A61K 31/196, A61K 31/397, A61K 31/40, A61K 31/4427, A61P 37/00, C07C 229/16, C07D 205/04, C07D 207/16, C07D 401/06
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12176689

N5-(2-ETHOXYETHYL)-N3-(2-PYRIDINYL) -3,5-PIPERIDINEDICARBOXAMIDE DERIVATIVES FOR USE AS RENIN INHIBITORS

IPC classification:
A61K 31/4545, A61P 9/12, C07D 401/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15719115

POLYCYCLIC HERG ACTIVATORS

IPC classification:
A61K 31/5025, A61P 9/06, C07D 405/04, C07D 405/12
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15733899

NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS

IPC classification:
A61K 31/519, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Georg von Sprecher, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature